Form 8-K - Current report:
SEC Accession No. 0001493152-24-026029
Filing Date
2024-07-02
Accepted
2024-07-02 16:40:31
Documents
19
Period of Report
2024-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 94709
2 AMENDMENT TO SERIES B DESIGNATION ex3-2.htm EX-3.2 17280
3 500,000 WARRANT AGREEMENT ex4-1.htm EX-4.1 115954
4 1,000,000 WARRANT AGREEMENT ex4-2.htm EX-4.2 116163
5 OMNIBUS AGREEMENT ex10-2.htm EX-10.2 49797
6 ex3-2_001.jpg GRAPHIC 253258
7 ex3-2_002.jpg GRAPHIC 114035
  Complete submission text file 0001493152-24-026029.txt   1151086

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE mgrx-20240426.xsd EX-101.SCH 3033
9 XBRL LABEL FILE mgrx-20240426_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE mgrx-20240426_pre.xml EX-101.PRE 22371
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3965
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 241096262
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)